Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-05-05Clinical Trial Update: Study of Immune Response Modifier in the Treatment of Hematologic Malignancies [Phase 2]
Phase 2 trial of an immune response modifier in hematologic malignancies has terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2010-04-02Clinical Trial Update: IFM 99-02 Thalidomide in Myeloma [Phase 3]
Phase 3 trial IFM 99-02 evaluating thalidomide in multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2010-04-02Clinical Trial Update: Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
A Phase 2 clinical trial evaluating bone marrow transplantation in patients with hematologic cancers has completed. The trial covered severa…
-
CLINICAL_TRIALS trial_result · 2010-03-17Clinical Trial Update: Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer [Phase 1]
Phase 1 clinical trial evaluating cyclophosphamide and/or mycophenolate mofetil with or without tacrolimus in patients undergoing donor bone…
-
CLINICAL_TRIALS trial_result · 2010-03-11Clinical Trial Update: Predictive Value of the "Cytocapacity Test" Patients With Lymphoproliferative Diseases and High-dose Therapy [Phase 2, Phase 3]
A completed Phase 2/Phase 3 trial evaluated the predictive value of the Cytocapacity Test in patients with Hodgkin lymphoma, Non-Hodgkin lym…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-03-10Clinical Trial Update: MS-275 in Treating Patients With Hematologic Cancer [Phase 1]
A Phase 1 trial of MS-275 (entinostat) in patients with hematologic cancers, including leukemia, multiple myeloma/plasma cell neoplasms, and…
-
CLINICAL_TRIALS trial_result · 2010-03-10Clinical Trial Update: Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [Phase 1]
Phase 1 trial of cyclophosphamide followed by bone marrow transplantation for hematologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2010-03-03Clinical Trial Update: CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma [Phase 3]
A Phase 3 trial comparing lenalidomide plus dexamethasone versus dexamethasone alone in previously treated multiple myeloma has completed, w…
-
CLINICAL_TRIALS trial_result · 2010-03-03Clinical Trial Update: Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple Myeloma [Phase 3]
Phase 3 expanded-access trial evaluating lenalidomide with or without dexamethasone in previously treated multiple myeloma completed, with r…
-
FDA approval · 2010-02-26FDA Approved: TREANDA — Supplemental Application (Cephalon, LLC)
The FDA approved a supplemental application for TREANDA (bendamustine hydrochloride) from Cephalon, LLC, enabling revisions to its labeling …
-
CLINICAL_TRIALS trial_result · 2010-02-22Clinical Trial Update: Study of XL999 in Patients With Multiple Myeloma [Phase 2]
A Phase 2 clinical trial of XL999 in patients with multiple myeloma was terminated.
-
CLINICAL_TRIALS trial_result · 2010-02-18Clinical Trial Update: Multiple Myeloma Treated With Thalidomide Before Autotransplant or With Conventional Chemotherapy and as Consolidation/Maintenance Treatment in Young and Elderly Patients : 3 Randomized Studies. [Phase 3]
Three randomized Phase 3 trials evaluate thalidomide as upfront therapy before autologous stem cell transplant or with conventional chemothe…
-
CLINICAL_TRIALS trial_result · 2010-02-02Clinical Trial Update: Thalidomide, Cyclophosphamide, Oral Idarubicin and Dexamethasone (T-CID) in Patients With Multiple Myeloma [Phase 2]
This is a Phase 2 clinical trial update evaluating the T-CID regimen (thalidomide, cyclophosphamide, oral idarubicin, and dexamethasone) in …
-
CLINICAL_TRIALS research · 2010-01-28Clinical Trial Update: Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders [Phase 2]
A Phase 2 clinical trial update evaluating stem cell transplantation for hematological cancers or related disorders, listing conditions such…
-
CLINICAL_TRIALS trial_result · 2010-01-26Clinical Trial Update: 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder [Phase 1]
This Phase 1 trial evaluating 12-O-tetradecanoylphorbol-13-acetate in hematologic cancers and bone marrow disorders was terminated.
-
CLINICAL_TRIALS trial_result · 2010-01-12Clinical Trial Update: Efficacy and Safety of Aprepitant in Subjects With Multiple Myeloma During and After High-dose Chemotherapy [Phase 3]
Phase 3 trial assessing the efficacy and safety of aprepitant in multiple myeloma patients during and after high-dose chemotherapy.
-
CLINICAL_TRIALS trial_result · 2010-01-12Clinical Trial Update: The Use of Dendritic Cell/Tumor Fusions as a Novel Tumor Vaccine in Patients With Multiple Myeloma [Phase 1]
A Phase 1 trial evaluating dendritic cell/tumor fusion vaccines as a novel immunotherapy for multiple myeloma has completed the study.
-
CLINICAL_TRIALS trial_result · 2009-12-14Clinical Trial Update: A Study of Aplidin (Plitidepsin) 3 h iv in Subjects With Relapsing or Refractory Multiple Myeloma [Phase 2]
Phase 2 study evaluating Aplidin (plitidepsin) given as a 3-hour IV infusion in relapsed or refractory multiple myeloma has completed, with …
-
CLINICAL_TRIALS trial_result · 2009-11-23Clinical Trial Update: Efficacy and Safety of Zoledronic Acid in Patients With Bone Metastases of Any Solid Tumors or Multiple Myeloma [Phase 3]
A Phase 3 clinical trial update evaluating the efficacy and safety of zoledronic acid in patients with bone metastases from solid tumors or …
-
CLINICAL_TRIALS other · 2009-11-23Clinical Trial Update: TKI258 in Subjects With Refractory or Relapsed Multiple Myeloma [Phase 1]
A Phase 1 trial of the agent TKI258 in subjects with refractory or relapsed multiple myeloma was terminated.
-
CLINICAL_TRIALS trial_result · 2009-11-16Clinical Trial Update: Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients
This update reports on a completed trial comparing piperacillin-tazobactam alone versus with a glycopeptide in neutropenic patients with hem…
-
CLINICAL_TRIALS trial_result · 2009-10-02Clinical Trial Update: Dendritic Cells(DC)-Based Id Vaccination in Stage-I Myeloma [Phase 1]
This ClinicalTrials.gov record reports a completed Phase 1 trial evaluating a dendritic cell-based idiotype vaccination in Stage I multiple …
-
CLINICAL_TRIALS trial_result · 2009-09-23Clinical Trial Update: Phase I, Multi-Center, Open-Label, Dose Escalation Study of HuLuc63 in Subjects With Advanced Multiple Myeloma [Phase 1]
A Phase I, multi-center, open-label dose-escalation study of HuLuc63 in subjects with advanced multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2009-09-23Clinical Trial Update: A Phase II Study of Continuous Versus Syncopated Dosing of CC-5013 for the Treatment of Refractory Multiple Myeloma [Phase 2]
Phase II study comparing continuous versus syncopated dosing of CC-5013 (lenalidomide) for refractory multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2009-09-18Clinical Trial Update: GEM05 for Patients With Multiple Myeloma Under 65 Years [Phase 3]
A Phase 3 clinical trial named GEM05 for patients with multiple myeloma under 65 years has completed.